Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 26/06/2019.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | Titulaire | VEIC | Type de demande | Date BA/ Courrier |
1 | TENSIOVALS 80 | VALSARTAN | 80mg | Cp pel sec | B/90 | TAHAPHARMA | E | N | 03/04/2019 |
2 | TENSIOVALS 160 | VALSARTAN | 80mg | Cp pel sec | B/90 | TAHAPHARMA | E | N | 03/04/2019 |
3 | TENSIOVALS DUO | VALSARTAN AMLODIPINE | 80mg /5mg | Cp pel sec | B/90 | TAHAPHARMA | E | N | 03/04/2019 |
4 | TENSIOVALS DUO | VALSARTAN AMLODIPINE | 160mg /5mg | Cp pel sec | B/90 | TAHAPHARMA | E | N | 03/04/2019 |
5 | TENSIOVALS DUO | VALSARTAN AMLODIPINE | 160mg /10mg | Cp pel sec | B/90 | TAHAPHARMA | E | N | 03/04/2019 |
6 | ACARLYSE | ACARBOSE | 50mg | cp | B/90 | SAIPH | E | N | 07/06/2019 |
7 | ACARLYSE | ACARBOSE | 100mg | cp | B/90 | SAIPH | E | N | 07/06/2019 |
8 | RIVA | RIVAROXABAN | 15mg | Cp pél | B/20 | PHILADELPHIA PHARMA | E | N | 14/06/2019 |
9 | RIVA | RIVAROXABAN | 15mg | Cp pél | B/40 | PHILADELPHIA PHARMA | E | N | 14/06/2019 |
10 | RIVA | RIVAROXABAN | 20mg | Cp pél | B/10 | PHILADELPHIA PHARMA | E | N | 14/06/2019 |
11 | RIVA | RIVAROXABAN | 20mg | Cp pél | B/30 | PHILADELPHIA PHARMA | E | N | 14/06/2019 |
12 | ASPEGIC ADULTES | Acétylsalicylate de lysine | 1000mg | Poudre pr sol orale | B/16 Sachets | SANOFI AVENTIS PHARMA | E | N | 19/06/2019 |
13 | LIPOMIN | FENOFIBRATE | 160 mg | Gélule | B/30 | WEST PHARMA | E | N | 20/06/2019 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | Titulaire | VEIC | Type de demande | Date BA |
1 | ALLORIC | Allopurinol | 100mg | cp | B/30 | ADVANS PHARMA | E | N | 14/06/2019 |
2 | BACLACINE 250 | Clarithromycine | 250mg | Cp pelliculé | B/10 | TAHA PHARMA | E | N | 14/06/2019 |
3 | BACLACINE 500 | Clarithromycine | 500mg | Cp pelliculé | B/14 | TAHA PHARMA | E | N | 14/06/2019 |
4 | FYLCOL | FLUCONAZOLE | 150 mg | Gélule | B/1 | TAHA PHARMA | E | N | 14/06/2019 |
5 | FYLCOL | FLUCONAZOLE | 150 mg | Gélule | B/2 | TAHA PHARMA | E | N | 14/06/2019 |
Spécialités Pharmaceutiques fabriquées localement :
* Produits déjà évalués lors des derniers Comités Techniques (AUDIT)
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | BICALUTAMIDE ACCORD | Bicalutamide | 50MG | CP PELLICUL | B/2 | ACCORD HAELTHCARE LIMITED UK | V | N | 05/06/2017 |
2 | LETROZOL ACCORD | LETROZOLE | 2,5 mg | COMPRIME | B/28 | ACCORD HAELTHCARE LIMITED UK | V | N | 29/08/2017 |
3 | FINASTERIDE ACCORD | Finasteride | 5mG | COMP PELLI | B/28 | ACCORD HAELTHCARE LIMITED UK | I | N | 21/05/2018 |
4 | METHOTREXATE ACCORD | METHOTREXATE | 50MG (25MG/ML) | SOL INJ | B/10FL/2ML | ACCORD HAELTHCARE LIMITED UK | V | N | 29/05/2018 |
5 | METHOTREXATE ACCORD | METHOTREXATE | 500MG(25MG/ML) | SOL INJ | B/10FL/20ML | ACCORD HAELTHCARE LIMITED UK | V | N | 29/05/2018 |
6 | EPIRUBICIN HCL ACCORD | EPIRUBICIN HCL | 10MG/5ML | SOL INJ PERF | B/1FL/5ML | ACCORD HEALTHCARE RU | V | N | 26/04/2019 |
7 | EPIRUBICIN HCL ACCORD | EPIRUBICIN HCL | 50MG/25ML | SOL INJ PERF | B/1FL/5ML | ACCORD HEALTHCARE RU | V | N | 26/04/2019 |
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE courrier |
1 | OZURDEX | DEXAMETHASONE | 700 MCG | SOL INTRA OCUL | B/1 | ALLERGAN | E | N | 04/09/2018 |
2 | TYSABRI | NATALIZUMAB | 300 MG | SOL PERF | BIOLOGIX | E | N | 05/09/2018 | |
3 | NATIMELLE | CALCIUM+VITAMINE D3 | 600MG/1000UI | COMP ORODISP | B/30 | ITALFARMACO | E | N | 10/09/2018 |
4 | PROTOPTIC | TACROLIMUS | 0,03% | PDE DRMIQUE | T/30GR | LEO PHARMA | E | N | 10/09/2018 |
5 | PROTOPTIC | TACROLIMUS | 0,10% | PDE DRMIQUE | T/30GR | LEO PHARMA | E | N | 10/09/2018 |
6 | VELCADE | BORTEZOMIB | 3,5MG% | pdre prep inj | B/1FL | JANSSEN CILAG | V | V | 10/09/2018 |
7 | LUTINUS | PROGESTERONE | 100mg | COMP VAGINALE | B/21 | FERRING PHARMACEUTICAL | E | N | 12/09/2018 |
8 | ENTRESTO | SACUBITRIL/VALSARTAN | 50MG | COMP PELL | B/28 | NOVARTIS PHARMA | E | N | 12/09/2018 |
9 | ENTRESTO | SACUBITRIL/VALSARTAN | 100MG | COMP PELL | B/56 | NOVARTIS PHARMA | E | N | 12/09/2018 |
10 | ENTRESTO | SACUBITRIL/VALSARTAN | 200MG | COMP PELL | B/56 | NOVARTIS PHARMA | E | N | 12/09/2018 |
11 | BLISSEL | ESTRIOL | 50µg/gr | gel vaginal | T/10 gr | ITALFARMACO | I | N | 25/09/2018 |
12 | EFFIENT | PRASUGREL | 5MG | COMPRIME PELLICULE | B/28 | DAIICHI SANKYO | E | N | 01/10/2018 |
13 | EFFIENT | PRASUGREL | 10MG | COMPRIME PELLICULE | B/28 | DAIICHI SANKYO | E | N | 01/10/2018 |
14 | TRESIBA FLEXTOUCH | INSULINE DEGLUDEC | 100UI/ML | SOL INJ | B/3 STYLOS/3ML | NOVONORDISK | V | N | 08/10/2018 |
15 | TRESIBA FLEXTOUCH | INSULINE DEGLUDEC | 200UI/ML | SOL INJ | B/3 STYLOS/3ML | NOVONORDISK | V | N | 08/10/2018 |
16 | AVASTIN | BEVACIZUMAB | 100MG | SOL INJ | B/1FL/4ML | ROCHE | V | V | 08/10/2018 |
17 | AVASTIN | BEVACIZUMAB | 400MG | SOL INJ | B/1FL/16ML | ROCHE | V | V | 08/10/2018 |
18 | PABAL | CARBETOCINE | 100MCG/ML | SOL INJ | B/5FL | FERRING PHARMACEUTICAL | E | N | 18/10/2018 |
19 | NUTRIFLEX LIPID PERI | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/2500ML | B BRAUN | V | N | 06/11/2018 | |
20 | NUTRIFLEX LIPID PERI | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/1250ML | B BRAUN | V | N | 06/11/2018 | |
21 | NUTRIFLEX LIPID PERI | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/1875ML | B BRAUN | V | N | 06/11/2018 | |
22 | NUTRIFLEX LIPID PLUS | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/2500ML | B BRAUN | V | N | 06/11/2018 | |
23 | NUTRIFLEX LIPID PLUS | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/1250ML | B BRAUN | V | N | 06/11/2018 | |
24 | NUTRIFLEX LIPID PLUS | AA +G +LIP +ELECTROLYTES | EMULSION PERF | P/1875ML | B BRAUN | V | N | 06/11/2018 | |
25 | RYZODEG FLEXTOUCH | INSULINE DEGLUDEC+INSULINE ASPARTE | STYLOS | B/5 | NOVONORDISK | V | N | 20/12/2018 | |
26 | PRILIGY | DAPOXETINE | 30mg | comp pell | B/3 | MENARINI | N | 04/01/2019 | |
27 | PRILIGY | DAPOXETINE | 60mg | comp pell | B/3 | MENARINI | N | 04/01/2019 | |
28 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/10ml | GE Healthcare Norvège | E | N | 07/01/2019 |
29 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/15ml | GE Healthcare Norvège | E | N | 07/01/2019 |
30 | CLARISCAN | ACIDE GADOTERIQUE | 0,05 mmol/ml | Sol inj | B/10fl/20ml | GE Healthcare Norvège | E | N | 07/01/2019 |
31 | STELARA | USTEKINUMAB | 45MG | SOL INJ | B/1 SERINGUE | JANSSEN CILAG | E | N | CS 08/01/2019 |
32 | STELARA | USTEKINUMAB | 45MG | SOL INJ | B/1FL | JANSSEN CILAG | E | N | CS 08/01/2019 |
33 | STELARA | USTEKINUMAB | 90MG | SOL INJ | B/1 SERINGUE | JANSSEN CILAG | E | N | CS 08/01/2019 |
34 | KEVESY | LEVETIRACETAM | 5MG/ML | SOL INJ PERFUSION | B/10 POCHES/100ML | STRAGEN | E | N | 18/01/2019 |
35 | KEVESY | LEVETIRACETAM | 10MG/ML | SOL INJ PERFUSION | B/10 POCHES/100ML | STRAGEN | E | N | 18/01/2019 |
36 | KEVESY | LEVETIRACETAM | 15MG/ML | SOL INJ PERFUSION | B/10 POCHES/100ML | STRAGEN | E | N | 18/01/2019 |
37 | TARGINACT | OXYCODINE HCL+NALOXONE HCL | 10/5MG | COMP LP | B/56 | NAPP PHARMACEUTICAL UK | V | N | 20/02/2019 |
38 | TARGINACT | OXYCODINE HCL+NALOXONE HCL | 20mg/10mg | COMP LP | B/56 | NAPP PHARMACEUTICAL UK | V | N | 20/02/2019 |
39 | TARGINACT | OXYCODINE HCL+NALOXONE HCL | 40/20MG | COMP LP | B/56 | NAPP PHARMACEUTICAL UK | V | N | 20/02/2019 |
40 | OFEV | NINTEDANIB | 150MG | CAPSULES MOLLES | B/60 | BOEHRINGER INGELHEIM | I | N | 06/03/2019 |
41 | PRAXBIND | IDARUCIZUMAB | 2,5G/50ML | SOL INJ PERFUSION | B/2FL/50ML | BOEHRINGER INGELHEIM | V | N | 15/03/2019 |
42 | PROLUTEX | PROGESTERONE | 25MG | SOL INJ | B/7FL | IBSA Institut Biochimique SA | N | 27/03/2019 | |
43 | ATACAND | Candesertan Cilexetil | 4mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
44 | ATACAND | Candesertan Cilexetil | 8mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
45 | ATACAND | Candesertan Cilexetil | 16mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
46 | MIRVASO | BRIMONIDINE TARTRATE | 3mg/gr | Gel dermique | T / 30gr | GALDERMA INTERNATIONAL | C | N | 22/05/2019 |
47 | XARELTO | RIVAROXABAN | 15mg | Cp | B42 | BAYER | E | N | 29/05/2019 |
48 | XARELTO | RIVAROXABAN | 15mg | Cp | B28 | BAYER | E | N | 29/05/2019 |
* Produits à évaluer pour la première fois au Comité Technique (AO)
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE courrier |
1 | Anastrozole Gerda | Anastrozole | 1mg | COMPRIME PELLICULE | B/30 | GERDA FRANCE | V | N | 26/10/2018 |
2 | XYLOCAINE VISQUEUSE | LIDOCAINE | 2% | GEL BUCCAL | T/100GR | ASTRA PHARMA | E | N | Transfert 16/05/2019 |
3 | PIPERACILLINE +TAZOBACTAM | PIPERACILLINE +TAZOBACTAM | 2G/250 MG | SOL PR PERFUSION | B/1F | MYLAN S.A.S | E | N | 12/06/2019 |
4 | PIPERACILLINE +TAZOBACTAM | PIPERACILLINE +TAZOBACTAM | 4G/500 MG | SOL PR PERFUSION | B/1F | MYLAN S.A.S | E | N | 12/06/2019 |
5 | VIDAZA 25 | AZACITIDINE | 25MG/ML | PDRE POUR SUSP INJ | B/1F | CELGENE EUROPE PAYS BAS | V | N | TRANSFERT26/06/2019 |
6 | FENTANYL PIRAMAL | FENTANYL | 100µG/2ML | SOL INJ | B/10AP/2ML | PIRAMAL CRITICAL CARE LIMITED | V | N | TRANSFERT 24/06/2019 |
7 | FENTANYL PIRAMAL | FENTANYL | 500µG/2ML | SOL INJ | B/10AP/10ML | PIRAMAL CRITICAL CARE LIMITED | V | N | TRANSFERT 26/06/2019 |
8 | NIMBEX | CISATRACURIUM | 2MG/ML | SOL INJ | B/5/5ML | ASPEN PHARMA TRADING LTD IRELANDE | V | N | TRANSFERT26/06/2019 |
9 | NIMBEX | CISATRACURIUM | 5MG/ML | SOL INJ | FL/30ML | ASPEN PHARMA TRADING LTD IRELANDE | V | N | TRANSFERT 26/06/2019 |
* Produits à évaluer pour la première fois au Comité Technique